Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trial.
Traditionally, subgroup analyses are used to assess whether patient characteristics moderate treatment effectiveness with general disregard for issues of multiplicity.Using data from The Action for Health in Diabetes (Look AHEAD) trial in the United States, we aim to identify a subgroup where all of its types of members experience a treatment benef